Cargando…
Immunotherapy in Colorectal Cancer: Current and Future Strategies
Despite the recent advances in the systemic treatment of metastatic colorectal cancer (mCRC), prognostic outcomes have remained to be poor. Thus, what is needed is an innovative treatment approach. Immune checkpoint inhibitors (ICIs) targeting programmed death-1 (PD-1) and anti-programmed cell death...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The Japan Society of Coloproctology
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7843143/ https://www.ncbi.nlm.nih.gov/pubmed/33537496 http://dx.doi.org/10.23922/jarc.2020-064 |